Aura Biosciences Forms Clinical Advisory Board In Ocular Oncology And Strengthens Clinical Team To Prepare For Clinical Development Of Lead Program In Ocular Melanoma

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells, announced today that it has formed a Clinical Advisory Board in Ocular Oncology and bolstered its clinical development team as it prepares to initiate clinical testing of its lead program in Ocular (uveal) Melanoma.

Help employers find you! Check out all the jobs and post your resume.